Valuing ResApp Health, page-185

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 185 Last

Share
Profile

Follow
rustys33

1,915 Posts.

539

22/05/22

19:22

Post #: 61553491
Share

Originally posted by DickyB: ↑

It’s been confirmed that it was in fact Freeman Road that sold around 38 million shares (all their holding) on Wednesday. They were the second largest shareholder.

This is a big play. Why would they sell out completely at 11 cents and why now?

Freeman Road have been involved since day one and had an average buy in price at under 2 cents so they’ve made a profit of over $3,500,000. You never go broke making a profit but their decision to pull the trigger now warrants some discussion, especially as they have very close links to a board member so would have all the information legally available.

I think we can assume that they strongly believe the vote would be NO at the current offer otherwise they’d have waited and received 11.5 cents or an additional $190,000. Not a small amount of money.

They may have many and varied reasons for selling out and good luck to them but this is the first big domino to fall IMO.

What do we glean from this?

Expand

I'm interested in who bought them. Maybe Pfizer bought this parcel and is picking some up on market. I'd be happy if they put a representative on the board.

If they did pickup 20% on market, the scheme is probably a reasonably clever way to acquire that many shares without sending the share price crazy.

RAP Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BTH

Deal done: Instos take control, locking in Bigtincan’s takeover

Friday's HotCopper Trends: Mesoblast dodges tariffs, Orthocell's FDA tick | April 4, 2025

RBA keeps rates on hold as world awaits Trump tariff fallout

Federal Budget underwhelms. Here's everything you'll want to know

AUK

Aumake secures exclusive deal with global goat milk brand Kabrita

HotCopper Highlights for Week 14 – Mesoblast, Cettire, Neurizon & more!

Week 14 Wrap: Tariffs tank markets as expected; will Rio Tinto ditch LSE?; EU ETFs soar

ELT

Elementos publishes robust DFS for Oropesa tin project

Listen: HotCopper Podcast 008 – Take-off time... or is it more taxiing?

PEK

Meet GeoGeorge: The HotCopper poster so accurate he found a career as a senior analyst

First 185 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Valuing ResApp Health, page-185

Top Stories

Deal done: Instos take control, locking in Bigtincan’s takeover

Friday's HotCopper Trends: Mesoblast dodges tariffs, Orthocell's FDA tick | April 4, 2025

RBA keeps rates on hold as world awaits Trump tariff fallout

Featured News